Akebia Therapeutics | 4:持股变动声明-高管 Hadas Nicole R.
Akebia Therapeutics | 4:持股变动声明-高管 Dahan Michel
Akebia Therapeutics | 4:持股变动声明-高管 Burke Steven Keith
Akebia Therapeutics | 4:持股变动声明-高管 Dahan Michel
Akebia Therapeutics | 4:持股变动声明-高管 Hadas Nicole R.
Akebia Therapeutics | 4:持股变动声明-高管 Butler John P.
Akebia Therapeutics | 4:持股变动声明-高管 Burke Steven Keith
Akebia Therapeutics | 4:持股变动声明-高管 Hadas Nicole R.
Akebia Therapeutics | 4:持股变动声明-高管 Dahan Michel
Akebia Therapeutics | 4:持股变动声明-高管 Burke Steven Keith
Akebia Therapeutics | 4:持股变动声明-高管 Butler John P.
Akebia Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(4.04%)
Akebia Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Muneer A. Satter(8.6%)
Akebia Therapeutics | 4:持股变动声明-高管 Grund Nicholas
Akebia Therapeutics | 4:持股变动声明-高管 Snow Ellen
Akebia Therapeutics | 4:持股变动声明-高管 Malabre Richard C
Akebia Therapeutics | 4:持股变动声明-高管 Dahan Michel
Akebia Therapeutics | 4:持股变动声明-高管 Hadas Nicole R.
Akebia Therapeutics | 4:持股变动声明-高管 Burke Steven Keith
Akebia Therapeutics | 4:持股变动声明-高管 Butler John P.
暂无数据